» Articles » PMID: 26157037

Hormone Receptor Expression in Spontaneous Uterine Adenocarcinoma in Fischer 344 Rats

Overview
Journal Toxicol Pathol
Publisher Sage Publications
Date 2015 Jul 10
PMID 26157037
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Most uterine cancers, the most common gynecological malignancies in women in developed countries, are hormone-dependent endometrial adenocarcinomas (EACs) that express estrogen and progesterone receptors. Although rat strains exist with a high spontaneous incidence of EAC, the Fischer 344 (F344) strain, previously one of the most commonly used strains in carcinogenicity testing, is not a high-incidence strain. To better understand the biology of this neoplasm, we assessed estrogen receptor α (ER), progesterone receptor (PR), and Ki-67 expression using immunohistochemistry in spontaneous EAC in 18 F344 rats used as control animals in 2-year National Toxicology Program bioassays. Of the 18 tumors, 9 were well-differentiated and 9 were poorly differentiated. Most tumors, 7/18, were ER+PR+, as observed in women. Of the remainder, 6/18 were ER+PR-, 2/18 were ER-PR+, and 3/18 were ER-PR-. Well-differentiated tumors were ER+ (8/9) more often than poorly differentiated tumors (5/9). The percentage of ER+ tumors (72%) in rats was similar to that seen in women, but rats less frequently had PR+ (50%) tumors than women. The heterogeneous estrogen and progesterone receptor immunophenotypes observed in F344 rats in this study highlight the importance of evaluating hormone receptor expression in animal models used for chemical evaluations.

Citing Articles

Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome.

Hernandez-Jerez A, Adriaanse P, Aldrich A, Berny P, Coja T, Duquesne S EFSA J. 2023; 21(2):e07744.

PMID: 36818642 PMC: 9926893. DOI: 10.2903/j.efsa.2023.7744.


Modeling Endometrial Cancer: Past, Present, and Future.

Van Nyen T, Moiola C, Colas E, Annibali D, Amant F Int J Mol Sci. 2018; 19(8).

PMID: 30096949 PMC: 6121384. DOI: 10.3390/ijms19082348.

References
1.
Carthew P, Edwards R, Nolan B, Martin E, Heydon R, White I . Tamoxifen induces endometrial and vaginal cancer in rats in the absence of endometrial hyperplasia. Carcinogenesis. 2000; 21(4):793-7. DOI: 10.1093/carcin/21.4.793. View

2.
Nagaoka T, Onodera H, Matsushima Y, Todate A, Shibutani M, Ogasawara H . Spontaneous uterine adenocarcinomas in aged rats and their relation to endocrine imbalance. J Cancer Res Clin Oncol. 1990; 116(6):623-8. DOI: 10.1007/BF01637084. View

3.
. Bioassay of 4,4'-thiodianiline for possible carcinogenicity. Natl Cancer Inst Carcinog Tech Rep Ser. 1978; 47:1-123. View

4.
Sorosky J . Endometrial cancer. Obstet Gynecol. 2012; 120(2 Pt 1):383-97. DOI: 10.1097/AOG.0b013e3182605bf1. View

5.
Haseman J, Hailey J, Morris R . Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: a National Toxicology Program update. Toxicol Pathol. 1998; 26(3):428-41. DOI: 10.1177/019262339802600318. View